Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05114733 · ClinicalTrials.gov registry record · NA
Individualized Vocational and Educational Support and Training for Clinical High Risk for Psychosis (InVEST)
A NA study, sponsored by Beth Israel Deaconess Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 26
- Enrollment target
NCT05114733 is a NA study that has completed, run by Beth Israel Deaconess Medical Center. The registered enrollment target is 26 participants.
The verdict
NCT05114733, a NA study, has completed, sponsored by Beth Israel Deaconess Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 26 participants
- Enrollment target
Study Summary
The purpose of this study is to test the efficacy of InVEST (Individualized Vocational and Educational Support and Training) for CHR-P (clinical high risk for psychosis) to address specific role functioning difficulties associated with the CHR-P phase. Our specific goals are: 1. Part 1: Preliminary open trial of InVEST (n = 8) to collect preliminary feasibility and acceptability data by providing the intervention, administering assessments, and collecting focus group and self-report feedback from open trial participants. The open trial phase will help to refine recruitment approaches and to modify the treatment manual as needed. 2. Part 2: Preliminary randomized controlled trial of InVEST vs. Delayed InVEST (DI) to explore preliminary evidence of efficacy of InVEST vs. DI (n = 30). The investigators hope to gain understanding of the feasibility of InVEST and the study's assessment procedures, and to gain a preliminary understanding of the intervention's efficacy for functioning difficulties experienced by young people at CHR-P.
Interventions
- BEHAVIORAL InVEST
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2022-02-22 |
| Est. Completion | 2025-09-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05114733
The ClinicalTrials.gov registry entry for NCT05114733 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 26 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Beth Israel Deaconess Medical Center, which has 488 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which InVEST is the first listed.
NCT05114733 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05114733 about?
NCT05114733 is a clinical study titled "Individualized Vocational and Educational Support and Training for Clinical High Risk for Psychosis (InVEST)". The purpose of this study is to test the efficacy of InVEST (Individualized Vocational and Educational Support and Training) for CHR-P (clinical high risk for psychosis) to address specific role functioning difficulties associated with the CHR-P phase. Our specific goals are: 1. Part 1: Preliminary...
What is the current status of trial NCT05114733?
This trial is currently completed. It is a NA study. The enrollment target is 26 participants. The study started on 2022-02-22. Estimated completion is 2025-09-15.
What interventions are being tested in trial NCT05114733?
The interventions under investigation include: InVEST (BEHAVIORAL).
Who is sponsoring clinical trial NCT05114733?
This trial is sponsored by Beth Israel Deaconess Medical Center, which has 488 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.